Literature DB >> 12441787

Neuroleptic malignant syndrome in the critical care unit.

Stanley N Caroff, Henry Rosenberg, Stephan C Mann, E Cabrina Campbell, Kenneth A Sullivan.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12441787     DOI： 10.1097/00003246-200211000-00043

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  5 in total

1.  Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.

Authors:  Azhar Supariwala; Gunjan Kant; Raymonde E Jean
Journal:  Intensive Care Med       Date:  2011-06-18       Impact factor: 17.440

2.  Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting?

Authors:  Deepali Dixit; Pranabh Shrestha; Marc Adelman
Journal:  BMJ Case Rep       Date:  2013-07-12

Review 3.  [Delirium in the intensive care unit].

Authors:  R von Haken; M Gruss; K Plaschke; M Scholz; R Engelhardt; A Brobeil; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2010-03       Impact factor: 1.041

4.  Olanzapine vs haloperidol: treating delirium in a critical care setting.

Authors:  Yoanna K Skrobik; Nicolas Bergeron; Marc Dumont; Stewart B Gottfried
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

5.  Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.

Authors:  Chee Keong Chang; Alvin Oliver Payus; Malehah Mohd Noh; Meryl Grace Lansing; Doreen Sumpat; Sooth Jiun Andrea Lu; Boon Teong Yew
Journal:  J Med Case Rep       Date:  2022-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.